Alberto González-González
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alberto González-González has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Flor Maria Perez-Campo
University of Cantabria, Santandery Torrelavega, Spain
5 shared publications - Daniel García-Sánchez
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Cantabria-IDIVAL, 39012 Santander, Spain
4 shared publications - José Carlos Rodríguez-Rey
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Cantabria-IDIVAL, 39012 Santander, Spain
3 shared publications - Itziar Álvarez-Iglesias
Departamento de Biología Molecular, Universidad de Cantabria-IDIVAL, 39011 Cantabria, Spain
2 shared publications - Jose Antonio Riancho
Servicio de Medicina Interna, Hospital U.M. Valdecilla, Santander, Spain; Universidad de Cantabria, Santander, Spain; Instituto de Investigación M. Valdecilla (IDIVAL), Santander, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain, Spain
2 shared publications - María Isabel Pérez-Núñez
Traumatology Service and Orthopedic Surgery, University Hospital “Marqués de Valdecilla” (UHMV), 39008 Santander, Spain
2 shared publications
Latest Publications
- Open Access
- 23 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1155
Bridging Osteoimmunology and Regenerative Therapy: The Role of MSCs and Extracellular Vesicles
Bone homeostasis and regeneration depend on tightly regulated interactions between skeletal cells and the immune system within the bone microenvironment. Disruption of this crosstalk by ageing, chronic inflammation, or systemic disease contributes to osteoporosis, inflammatory bone loss, and impaired fracture healing. Osteoimmunology has reframed bone biology as an immune-regulated process, highlighting mesenchymal stem cells (MSCs) as central coordinators of bone-immune communication. Beyond their differentiation capacity, MSCs act primarily through paracrine mechanisms, releasing a secretome composed of soluble factors and extracellular vesicles (EVs) that modulate immune responses, regulate osteoblast and osteoclast activity, promote angiogenesis, and support extracellular matrix remodelling. MSC-derived EVs have emerged as key nanoscale mediators that transfer bioactive cargo to target cells in a context-dependent manner, enabling precise regulation of osteoimmune processes. This review summarises current knowledge on the role of MSCs in osteoimmunology, with a focus on how their secretome and EVs integrate immune modulation with bone regeneration. We discuss the mechanisms underlying MSC-mediated regulation of innate and adaptive immune cells, examine emerging cell-free therapeutic strategies based on secretome and EV delivery, and outline the main challenges that must be addressed to advance these approaches towards clinical application.
- 23 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1155
Open AccessBridging Osteoimmunology and Regenerative Therapy: The Role of MSCs and Extracellular Vesicles
Bone homeostasis and regeneration depend on tightly regulated interactions between skeletal cells and the immune system within the bone microenvironment. Disruption of this crosstalk by ageing, chronic inflammation, or systemic disease contributes to osteoporosis, inflammatory bone loss, and impaired fracture healing. Osteoimmunology has reframed bone biology as an immune-regulated process, highlighting mesenchymal stem cells (MSCs) as central coordinators of bone-immune communication. Beyond their differentiation capacity, MSCs act primarily through paracrine mechanisms, releasing a secretome composed of soluble factors and extracellular vesicles (EVs) that modulate immune responses, regulate osteoblast and osteoclast activity, promote angiogenesis, and support extracellular matrix remodelling. MSC-derived EVs have emerged as key nanoscale mediators that transfer bioactive cargo to target cells in a context-dependent manner, enabling precise regulation of osteoimmune processes. This review summarises current knowledge on the role of MSCs in osteoimmunology, with a focus on how their secretome and EVs integrate immune modulation with bone regeneration. We discuss the mechanisms underlying MSC-mediated regulation of innate and adaptive immune cells, examine emerging cell-free therapeutic strategies based on secretome and EV delivery, and outline the main challenges that must be addressed to advance these approaches towards clinical application.
- Open Access
- 17 June 2025
- Published by Universidad Nacional de Colombia in Acta Odontológica Colombiana
- Vol. 14 (2)
Ansiedad y depresión como factores relacionados en manifestaciones de patologías en la cavidad oral. Una revisión narrativa
El odontólogo, como profesional de la salud quien se ocupa del cuidado, diagnóstico, pronóstico y tratamiento de los órganos dentarios, la cavidad oral y las estructuras asociadas, debe velar por la salud integral del paciente reconociendo la existencia de patologías orales como la sequedad bucal inducida por antidepresivos, las caries dentales, la pérdida de órganos dentarios, entre otras enfermedades asociadas con trastornos de ansiedad y depresión. El propósito de esta revisión consiste en generar interés en el profesional de odontología respecto a la relación existente entre los trastornos de ansiedad y depresión con la presencia de enfermedades que afectan el estado de salud de la cavidad oral, para eso se realizó una búsqueda de registros en Pubmed donde los resultados muestran que el odontólogo como parte del equipo de atención en salud, puede contribuir en el mejoramiento del estado de salud general de forma oportuna y eficaz, derivando con los profesionales involucrados en la atención interdisciplinaria reflexionando acerca de la atención integral del paciente, evidenciar diagnósticos generales que influyen el estado de salud bucal. Conclusiones: La salud oral es fundamental para el bienestar general. Es necesario la inclusión en los programas nacionales de salud de personas que padezcan ansiedad y depresión. Crear programas específicos de prevención, es una de las recomendaciones sugeridas como soluciones. El propósito del documento consiste en generar interés en el profesional de odontología respecto a la relación existente entre los trastornos de ansiedad y depresión con la presencia de enfermedades que afectan el estado de salud de la cavidad oral, resaltando que el odontólogo como parte del equipo de atención en salud, pueda contribuir en el mejoramiento del estado de salud general de forma oportuno y eficaz, derivando con los profesionales involucrados en la atención interdisciplinaria reflexionando acerca de la atención integral del paciente, evidenciar diagnósticos generales que influyen el estado de salud bucal. Conclusiones: La salud oral es fundamental para el bienestar general. Es necesario la inclusión en los programas nacionales de salud de personas que padezcan ansiedad y depresión. Crear programas específicos de prevención, es una de las recomendaciones sugeridas como soluciones.
- 17 June 2025
- Published by Universidad Nacional de Colombia in Acta Odontológica Colombiana
- Vol. 14 (2)
Open AccessAnsiedad y depresión como factores relacionados en manifestaciones de patologías en la cavidad oral. Una revisión narrativa
El odontólogo, como profesional de la salud quien se ocupa del cuidado, diagnóstico, pronóstico y tratamiento de los órganos dentarios, la cavidad oral y las estructuras asociadas, debe velar por la salud integral del paciente reconociendo la existencia de patologías orales como la sequedad bucal inducida por antidepresivos, las caries dentales, la pérdida de órganos dentarios, entre otras enfermedades asociadas con trastornos de ansiedad y depresión. El propósito de esta revisión consiste en generar interés en el profesional de odontología respecto a la relación existente entre los trastornos de ansiedad y depresión con la presencia de enfermedades que afectan el estado de salud de la cavidad oral, para eso se realizó una búsqueda de registros en Pubmed donde los resultados muestran que el odontólogo como parte del equipo de atención en salud, puede contribuir en el mejoramiento del estado de salud general de forma oportuna y eficaz, derivando con los profesionales involucrados en la atención interdisciplinaria reflexionando acerca de la atención integral del paciente, evidenciar diagnósticos generales que influyen el estado de salud bucal. Conclusiones: La salud oral es fundamental para el bienestar general. Es necesario la inclusión en los programas nacionales de salud de personas que padezcan ansiedad y depresión. Crear programas específicos de prevención, es una de las recomendaciones sugeridas como soluciones. El propósito del documento consiste en generar interés en el profesional de odontología respecto a la relación existente entre los trastornos de ansiedad y depresión con la presencia de enfermedades que afectan el estado de salud de la cavidad oral, resaltando que el odontólogo como parte del equipo de atención en salud, pueda contribuir en el mejoramiento del estado de salud general de forma oportuno y eficaz, derivando con los profesionales involucrados en la atención interdisciplinaria reflexionando acerca de la atención integral del paciente, evidenciar diagnósticos generales que influyen el estado de salud bucal. Conclusiones: La salud oral es fundamental para el bienestar general. Es necesario la inclusión en los programas nacionales de salud de personas que padezcan ansiedad y depresión. Crear programas específicos de prevención, es una de las recomendaciones sugeridas como soluciones.
- Open Access
- 3 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (15) , 12399
Engineering a Pro-Osteogenic Secretome through the Transient Silencing of the Gene Encoding Secreted Frizzled Related Protein 1
The evidence sustaining the regenerative properties of mesenchymal stem cells’ (MSCs) secretome has prompted a paradigm change, where MSCs have shifted from being considered direct contributors to tissue regeneration toward being seen as cell factories for producing biotech medicines. We have previously designed a method to prime MSCs towards osteogenic differentiation by silencing the Wnt/β-Catenin inhibitor Sfpr1. This approach produces a significant increase in bone formation in osteoporotic mice. In this current work, we set to investigate the contribution of the secretome from the MSCs where Sfrp1 has been silenced, to the positive effect seen on bone regeneration in vivo. The conditioned media (CM) of the murine MSCs line C3H10T1/2, where Sfrp1 has been transiently silenced (CM-Sfrp1), was found to induce, in vitro, an increase in the osteogenic differentiation of this same cell line, as well as a decrease of the expression of the Wnt inhibitor Dkk1 in murine osteocytes ex vivo. A reduction in the RANKL/OPG ratio was also detected ex vivo, suggesting a negative effect of CM-Sfrp1 on osteoclastogenesis. Moreover, this CM significantly increases the mineralization of human primary MSCs isolated from osteoportotic patients in vitro. Proteomic analysis identified enrichment of proteins involved in osteogenesis within the soluble and vesicular fractions of this secretome. Altogether, we demonstrate the pro-osteogenic potential of the secretome of MSCs primmed in this fashion, suggesting that this is a valid approach to enhance the osteo-regenerative properties of MSCs’ secretome.
- 3 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (15) , 12399
Open AccessEngineering a Pro-Osteogenic Secretome through the Transient Silencing of the Gene Encoding Secreted Frizzled Related Protein 1
The evidence sustaining the regenerative properties of mesenchymal stem cells’ (MSCs) secretome has prompted a paradigm change, where MSCs have shifted from being considered direct contributors to tissue regeneration toward being seen as cell factories for producing biotech medicines. We have previously designed a method to prime MSCs towards osteogenic differentiation by silencing the Wnt/β-Catenin inhibitor Sfpr1. This approach produces a significant increase in bone formation in osteoporotic mice. In this current work, we set to investigate the contribution of the secretome from the MSCs where Sfrp1 has been silenced, to the positive effect seen on bone regeneration in vivo. The conditioned media (CM) of the murine MSCs line C3H10T1/2, where Sfrp1 has been transiently silenced (CM-Sfrp1), was found to induce, in vitro, an increase in the osteogenic differentiation of this same cell line, as well as a decrease of the expression of the Wnt inhibitor Dkk1 in murine osteocytes ex vivo. A reduction in the RANKL/OPG ratio was also detected ex vivo, suggesting a negative effect of CM-Sfrp1 on osteoclastogenesis. Moreover, this CM significantly increases the mineralization of human primary MSCs isolated from osteoportotic patients in vitro. Proteomic analysis identified enrichment of proteins involved in osteogenesis within the soluble and vesicular fractions of this secretome. Altogether, we demonstrate the pro-osteogenic potential of the secretome of MSCs primmed in this fashion, suggesting that this is a valid approach to enhance the osteo-regenerative properties of MSCs’ secretome.
- 8 November 2022
- Published by Springer Nature
- p. 1123-1158
Regenerative Medicine Applied to the Treatment of Musculoskeletal Pathologies
- 8 November 2022
- Published by Springer Nature
- p. 1123-1158
Regenerative Medicine Applied to the Treatment of Musculoskeletal Pathologies
- Open Access
- 18 April 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (4) , 648
Histological Profiling of the Human Umbilical Cord: A Potential Alternative Cell Source in Tissue Engineering
The embryonic development of the human umbilical cord (hUC) is complex, and different regions can be identified in this structure. The aim of this work is to characterize the hUC at in situ and ex vivo levels to stablish their potential use in vascular regeneration. Human umbilical cords were obtained and histologically prepared for in the situ analysis of four hUC regions (intervascular—IV, perivascular—PV, subaminoblastic—SAM, and Wharton’s jelly—WH), and primary cell cultures of mesenchymal stem cells (hUC-MSC) isolated from each region were obtained. The results confirmed the heterogeneity of the hUC, with the IV and PV zones tending to show the higher in situ expression of several components of the extracellular matrix (collagens, proteoglycans, and glycosaminoglycans), vimentin, and MSC markers (especially CD73), although isolation and ex vivo culture resulted in a homogeneous cell profile. Three vascular markers were positive in situ, especially vWF, followed by CD34 and CD31, and isolation and culture revealed that the region associated with the highest expression of vascular markers was IV, followed by PV. These results confirm the heterogeneity of the hUC and the need for selecting cells from specific regions of the hUC for particular applications in tissue engineering.
- 18 April 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (4) , 648
Open AccessHistological Profiling of the Human Umbilical Cord: A Potential Alternative Cell Source in Tissue Engineering
The embryonic development of the human umbilical cord (hUC) is complex, and different regions can be identified in this structure. The aim of this work is to characterize the hUC at in situ and ex vivo levels to stablish their potential use in vascular regeneration. Human umbilical cords were obtained and histologically prepared for in the situ analysis of four hUC regions (intervascular—IV, perivascular—PV, subaminoblastic—SAM, and Wharton’s jelly—WH), and primary cell cultures of mesenchymal stem cells (hUC-MSC) isolated from each region were obtained. The results confirmed the heterogeneity of the hUC, with the IV and PV zones tending to show the higher in situ expression of several components of the extracellular matrix (collagens, proteoglycans, and glycosaminoglycans), vimentin, and MSC markers (especially CD73), although isolation and ex vivo culture resulted in a homogeneous cell profile. Three vascular markers were positive in situ, especially vWF, followed by CD34 and CD31, and isolation and culture revealed that the region associated with the highest expression of vascular markers was IV, followed by PV. These results confirm the heterogeneity of the hUC and the need for selecting cells from specific regions of the hUC for particular applications in tissue engineering.
- Open Access
- 17 August 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (8) , 1277
Effective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing
Mesenchymal stem cell (MSC) transplantation has emerged as a promising approach for bone regeneration. Importantly, the beneficial effects of MSCs can be improved by modulating the expression levels of specific genes to stimulate MSC osteogenic differentiation. We have previously shown that Smurf1 silencing by using Locked Nucleic Acid-Antisense Oligonucleotides, in combination with a scaffold that sustainably releases low doses of BMP-2, was able to increase the osteogenic potential of MSCs in the presence of BMP-2 doses significantly smaller than those currently used in the clinic. This would potentially allow an important reduction in this protein in MSs-based treatments, and thus of the side effects linked to its administration. We have further improved this system by specifically targeting the Wnt pathway modulator Sfrp1. This approach not only increases MSC bone regeneration efficiency, but is also able to induce osteogenic differentiation in osteoporotic human MSCs, bypassing the need for BMP-2 induction, underscoring the regenerative potential of this system. Achieving successful osteogenesis with the sole use of LNA-ASOs, without the need of administering pro-osteogenic factors such as BMP-2, would not only reduce the cost of treatments, but would also open the possibility of targeting these LNA-ASOs specifically to MSCs in the bone marrow, allowing us to treat systemic bone loss such as that associated with osteoporosis.
- 17 August 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (8) , 1277
Open AccessEffective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing
Mesenchymal stem cell (MSC) transplantation has emerged as a promising approach for bone regeneration. Importantly, the beneficial effects of MSCs can be improved by modulating the expression levels of specific genes to stimulate MSC osteogenic differentiation. We have previously shown that Smurf1 silencing by using Locked Nucleic Acid-Antisense Oligonucleotides, in combination with a scaffold that sustainably releases low doses of BMP-2, was able to increase the osteogenic potential of MSCs in the presence of BMP-2 doses significantly smaller than those currently used in the clinic. This would potentially allow an important reduction in this protein in MSs-based treatments, and thus of the side effects linked to its administration. We have further improved this system by specifically targeting the Wnt pathway modulator Sfrp1. This approach not only increases MSC bone regeneration efficiency, but is also able to induce osteogenic differentiation in osteoporotic human MSCs, bypassing the need for BMP-2 induction, underscoring the regenerative potential of this system. Achieving successful osteogenesis with the sole use of LNA-ASOs, without the need of administering pro-osteogenic factors such as BMP-2, would not only reduce the cost of treatments, but would also open the possibility of targeting these LNA-ASOs specifically to MSCs in the bone marrow, allowing us to treat systemic bone loss such as that associated with osteoporosis.
- Open Access
- 26 December 2020
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 12 (12) , 1529-1552
Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine
Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine
- 26 December 2020
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 12 (12) , 1529-1552
Open AccessMesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine
Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine